Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches.
- DOI
- 10.2174/0113816128486412260828111209
- Published
- 2026 Sep 10
- Container
- Current pharmaceutical design
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0113816128486412260828111209,
title = {Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches.},
author = {Ansari S and Saifi MA and Ahmed S and Kumar A and Alam M and Teotia D and Nandi S},
year = {2026},
journal = {Current pharmaceutical design},
doi = {10.2174/0113816128486412260828111209},
url = {https://doi.org/10.2174/0113816128486412260828111209}
}RIS
TY - JOUR TI - Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches. AU - Ansari S AU - Saifi MA AU - Ahmed S AU - Kumar A AU - Alam M AU - Teotia D AU - Nandi S PY - 2026 JO - Current pharmaceutical design DO - 10.2174/0113816128486412260828111209 UR - https://doi.org/10.2174/0113816128486412260828111209 ER -
APA
S, A., MA, S., S, A., A, K., M, A., D, T., & S, N. (2026). Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches.. Current pharmaceutical design. https://doi.org/10.2174/0113816128486412260828111209
Source records
- pubmed · retrieved 2026-09-26T08:19:42.196Z